• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Redwoods Acquisition Corp. Announces Receipt of Nasdaq Listing Delinquency Letter and Nasdaq Listing Compliance Determination Letter

    5/31/23 4:15:00 PM ET
    $RWOD
    Blank Checks
    Finance
    Get the next $RWOD alert in real time by email

    NEW YORK, May 31, 2023 /PRNewswire/ -- Redwoods Acquisition Corp. (the "Company") (NASDAQ:RWOD) today announced that it received a delinquency notification letter ("Notice") from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") on May 24, 2023 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 (the "Form 10-Q"). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC").

    The Company filed the Form 10-Q with the SEC on May 24, 2023.

    On May 30, 2023, the Company received a letter from Nasdaq indicating that based on the Company's May 24, 2023 filing of the Form 10-Q, the staff has determined that the Company has complied with the Listing Rule and, accordingly, the matter was closed. As a result, the Company is currently in compliance with the Nasdaq Listing Rules and the Company's securities will continue to trade on The Nasdaq Global Market.

    This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

    About Redwoods Acquisition Corp.

    Redwoods Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected a business combination target. Although there is no restriction or limitation on what industry or geographic region its target operates in, the Company intends to focus on the carbon neutral and energy storage industries. The Company is led by its Chief Executive Officer, Jiande Chen.

    Forward-Looking Statements

    This announcement contains forward-looking statements, including statements about the financial condition, results of operations, earnings outlook and prospects of the Company. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.

    The forward-looking statements are based on the current expectations of the Company's management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These factors include, without limitation, our ability to respond in a timely and satisfactory matter to the inquiries by Nasdaq, our ability to regain compliance with Listing Rule and our ability to become current with our reports with the SEC. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the SEC. Forward-looking statements represent management's current expectations and are inherently uncertain. Except to the extent required by applicable law, we do not undertake any obligation to update or revise forward-looking statements made by us to reflect subsequent events or circumstances.

     

    Cision View original content:https://www.prnewswire.com/news-releases/redwoods-acquisition-corp-announces-receipt-of-nasdaq-listing-delinquency-letter-and-nasdaq-listing-compliance-determination-letter-301838974.html

    SOURCE Redwoods Acquisition Corp

    Get the next $RWOD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RWOD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RWOD
    SEC Filings

    View All

    SEC Form 25-NSE filed by Redwoods Acquisition Corp.

    25-NSE - Redwoods Acquisition Corp. (0001907223) (Subject)

    6/21/24 4:56:47 PM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form 425 filed by Redwoods Acquisition Corp.

    425 - Redwoods Acquisition Corp. (0001907223) (Subject)

    6/20/24 1:17:06 PM ET
    $RWOD
    Blank Checks
    Finance

    Redwoods Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Redwoods Acquisition Corp. (0001907223) (Filer)

    6/20/24 1:14:35 PM ET
    $RWOD
    Blank Checks
    Finance

    $RWOD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ANEW MEDICAL, INC. COMMENCES TRADING ON NASDAQ UNDER TICKER SYMBOL, "WENA"

    NEW YORK, June 24, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or the "Company") announces the Company's common shares and warrants will begin trading on the NASDAQ Global Market under the ticker symbols "WENA" and "WENAW", respectively. ANEW is a specialty pharmaceutical company specializing in the advancement of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. Dr. Joseph Sinkule, Founder and CEO of ANEW, commented, "Today marks our first day as a publicly traded company and as a dedicated leader in the development of novel disease-modifying therapies for neurological and age-related disorders. We're a relatively new company but our manageme

    6/24/24 10:50:00 AM ET
    $RWOD
    Blank Checks
    Finance

    ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP. ANNOUNCE CLOSING OF THEIR BUSINESS COMBINATION

    ANEW MEDICAL, INC.'s shares and warrants are expected to begin trading on the Nasdaq Global Market under the tickers "WENA" and "WENAW", respectively.  NEW YORK, NY, June 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. ("ANEW" or the "Company"), a biopharmaceutical technology company focused on developing disruptive new therapies to treat the central nervous system ("CNS") and neurodegenerative diseases, and Redwoods Acquisition Corp. (NASDAQ: RWOD) ("RWOD"), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination"). The combined company will be named "ANEW MEDICAL, INC." a

    6/21/24 4:45:00 PM ET
    $RWOD
    Blank Checks
    Finance

    ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS

    NEW YORK, March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSITAT AUTÒNOMA DE BARCELONA (UAB) and INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA) in Barcelona, Spain on an exclusive worldwide basis and ANEW paid

    3/4/24 5:00:00 AM ET
    $RWOD
    Blank Checks
    Finance

    $RWOD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/22/24 9:10:07 AM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/13/24 1:13:31 PM ET
    $RWOD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Redwoods Acquisition Corp. (Amendment)

    SC 13G/A - Redwoods Acquisition Corp. (0001907223) (Subject)

    2/14/23 12:13:20 PM ET
    $RWOD
    Blank Checks
    Finance